GlassScriptPhysician profile
Grant R Seeger
NPI 1427252014
$30,959.68
in general payments reported to CMS, 2019-2025
25 companies · $3,076 in 2025
The $3,076 reported for 2025 was more than what 93% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,837 · 2020: $271 · 2021: $3,530 · 2022: $2,490 · 2023: $14K · 2024: $3,482 · 2025: $3,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,500 · Travel and Lodging: $4,814 · Food and Beverage: $4,019 · Honoraria: $4,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,500.00 |
| Travel and Lodging | $4,813.67 |
| Food and Beverage | $4,018.52 |
| Honoraria | $4,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accuray Incorporated | $15,467.27 | 2019-2025 | Tomo Therapy System, Cyberknife System |
| Pfizer INC. | $5,140.54 | 2023 | |
| Merck Sharp & Dohme LLC | $2,634.18 | 2024-2025 | |
| Telix Pharmaceuticals | $2,048.46 | 2025 | Illuccix |
| Varian Medical Systems, INC. | $1,133.81 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $1,084.25 | 2021-2025 | Truebeam |
| Novocure INC. | $643.30 | 2019-2025 | Optune, Optune Lua (Novottf-200t), Optune Gio |
| Astrazeneca Pharmaceuticals LP | $380.08 | 2021-2025 | Imfinzi, Wainua |
| Reflexion Medical, INC. | $356.96 | 2023 | Reflexion Medical Radiotherapy System |
| Elekta, INC. | $341.37 | 2019-2023 | Elekta Medical Linear Accelerator |
| Tempus Ai, INC | $302.15 | 2024-2025 | Xt Cdx |
| Palette Life Sciences, INC. | $267.36 | 2022-2023 | |
| Boston Scientific Corporation | $265.98 | 2019-2025 | Spaceoar Vue System - 10ml |
| Ge Healthcare | $147.90 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $120.42 | 2022-2023 | Rybrevant |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zap Surgical Systems, INC. | $115.53 | 2021 | |
| Veran Medical Technologies, INC. | $109.85 | 2019-2020 | |
| Brainlab, INC. | $90.06 | 2021 | |
| Novartis Pharmaceuticals Corporation | $69.41 | 2025 | |
| Stemline Therapeutics INC. | $67.29 | 2025 | Orserdu |
| Northern X-Ray Company | $66.20 | 2019 | |
| Stryker Corporation | $37.86 | 2024 | Optablate |
| Genentech USA, INC. | $33.19 | 2019 | |
| Daiichi Sankyo INC. | $18.52 | 2025 | Enhertu |
| Sumitomo Pharma America, INC. | $17.74 | 2025 | Orgovyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Seeger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.